Calithera Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.00
|
|
Average Rating
|
3.33
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.93
|
-2.01
|
-0.08
|
-4.15%
|
|
2022-06-30
|
-2.65
|
-1.59
|
1.06
|
40.00%
|
|
2022-03-31
|
-3.70
|
-3.60
|
0.10
|
2.70%
|
|
2021-12-31
|
-4.80
|
-4.80
|
0.00
|
0.00%
|
|
2021-09-30
|
-4.56
|
-3.00
|
1.56
|
34.21%
|
|
2021-06-30
|
-4.81
|
-3.80
|
1.01
|
21.00%
|
|
2021-03-31
|
-5.52
|
-5.60
|
-0.08
|
-1.45%
|
|
2020-12-31
|
-6.48
|
-6.40
|
0.08
|
1.23%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-7.20
|
|
2021-12-31
|
-17.20
|
|
2020-12-31
|
-18.98
|
|
2019-12-31
|
-1.96
|
|
2018-12-31
|
-1.49
|
|
2017-12-31
|
-0.85
|
|
2016-12-31
|
-1.96
|
|
2015-12-31
|
-1.81
|
|
2014-12-31
|
-17.24
|